Effect of luseogliflozin on hepatic fat content in type 2 diabetes patients with non ‐alcoholic fatty liver disease: A prospective, single‐arm trial (LEAD trial)

Hepatology Research, EarlyView.

Source: Hepatology Research - September 1, 2018 Category: Internal Medicine Authors: YoshioSumida , KentaMurotani , MiyokoSaito , AtsukoTamasawa , YusukeOsonoi , MasashiYoneda , TakeshiOsonoi Source Type: research